Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Post-marketing Safety Measures

Revisions of PRECAUTIONS (FY2024)

Date Nonproprietary name
(Click on each regenerative medical product name for more information
[only in Japanese])
Detailed information on revisions of PRECAUTIONS (from MHLW) Summary of investigation results (from PMDA)
March 5,
2025
Axicabtagene ciloleucel
Idecabtagene vicleucel
Tisagenlecleucel
Lisocabtagene maraleucel
PRECAUTIONS
[16.8 KB]
Summary of
Investigation
[77.1 KB]
Ciltacabtagene autoleucel PRECAUTIONS
[16.1 KB]
Summary of
Investigation
[77.1 KB]